TURNING BREAKTHROUGH SCIENCE INTO REGULATORY SUCCESS

Turning Breakthrough Science Into Regulatory Success

Exellerium AB is a global regulatory affairs (RA) consultancy based in Sweden, specializing in accelerating the development and approval of innovative products for biotech, pharmaceutical, and medtech leaders.

We provide end-to-end strategic guidance from early discovery to market launch, combining deep scientific understanding with regulatory expertise to de-risk development and maximize speed-to-market.

Get Started

Our Services

Comprehensive Regulatory Strategies for Success

Explore our tailored services designed to streamline your development and market entry processes with unparalleled expertise.

Regulatory Strategy

Crafting tailored regulatory pathways to ensure expedited approval.

Submission Leadership

We take the lead in preparing clinical trial applications, pediatric study plans, and marketing authorizations.

Agency Interaction Support

We prepare and support your meetings with agencies such as the European Medicines Agency and the U.S. Food and Drug Administration.

Accelerated Designations

We prepare requests for programs that speed up approval, such as Orphan Drug, Fast Track, Breakthrough Therapy, Regenerative Medicine Advanced Therapy and PRIME designations.

Why Choose Us

Unmatched Regulatory Expertise

Global Reach

With experience across multiple countries, we provide insights that drive successful regulatory pathways tailored to your product’s unique needs.

End-to-End Support

We accompany you throughout the entire regulatory process, from early discovery to marketing authorization, ensuring a stress-free experience.

Tailored Strategies

Our custom regulatory strategies are designed to fit the intricacies of cell and gene therapies, biologics, and more, maximizing development efficiency.

Innovative Partnerships

Partnering with startups to bring pioneering ideas to life, we provide essential regulatory guidance and investment for future success.